FTC
-
Adobe settles for $150m over hard-to-cancel subscriptions
The case shows the DOJ is still willing to go after large companies that use sticky subscription models, even though some have criticized the settlement as lenient.
-
FTC Chair flags potential antitrust risks in law firms’ DEI hiring programs
FTC argues that coordination between competitors in how they make employment decisions could violate federal law.
-
Podcast: Jeffrey Oliver tells us about the state of antitrust policy and enforcement in 2026
Jeffrey Oliver talked to GRIP about the surging pace of antitrust activity in 2026 and what we can expect from regulators in this space.
-
FTC resolves Express Scripts case with ‘landmark settlement’
The pharmacy benefits manager has copped to artificially inflating the list price of drugs by using unfair rebating practices.
-
FTC accuses Amazon execs of using Signal to auto-delete messages, destroy evidence
The FTC said the absence of Signal messages from Amazon discussing substantive business issues relevant to the antitrust case against the company meant those messaged had “disappeared.”
-
A transformational 2025 in US healthcare – and more to come in 2026
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
-
Podcast: Barry Posner on healthcare M&A diligence and regulatory change
Against a backdrop of uncertain times for healthcare M&A, we spoke to Barry Posner, partner at Kudman Trachten Aloe Posner LLP.
-
Proxy advisers ISS and Glass Lewis targeted by FTC antitrust probe
Critics have long expressed concerns regarding the two firms’ influence on corporate governance.